Saturday, October 3, 2026

EUR/CHF Bearish Momentum With A 2% Slide In The Last 21 Sessions

EUR/CHF Bearish Momentum With A 2% Slide In The Last 21 Sessions

(VIANEWS) - EUR/CHF (EURCHF) has been up by 2.5% for the last 21 sessions. At 01:06 EST on Thursday, 27 July, EUR/CHF (EURCHF) is $0.95.

EUR/CHF's yearly highs and lows, it's 1.198% up from its 52-week low and 5.497% down from its 52-week high.

Volatility

EUR/CHF's last week, last month's, and last quarter's current intraday variation average was a negative 0.14%, a negative 0.12%, and a positive 0.22%, respectively.

EUR/CHF's highest amplitude of average volatility was 0.28% (last week), 0.21% (last month), and 0.22% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, EUR/CHF's Forex is considered to be overbought (>=80).

News about

  • Eur/usd: support at 1.1050 to remain under pressure heading into FOMC meeting – ING. According to FXStreet on Tuesday, 25 July, "We still see some downside risks to EUR/USD from the Dollar side later this week.", "It is possible we see a very narrow range in EUR/USD today, something like 1.1050-1.1100, where the pro-growth China news may be the only factor holding EUR/USD above 1.1050."
  • According to FXStreet on Tuesday, 25 July, "Further downside, the EUR/USD pair should meet immediate contention at theweekly low of 1.1041 ahead of the psychological 1.1000 mark, all seconded by provisional support at the 55-day and 100-day Simple Moving Averages (SMA) at 1.0900 and 1.0890, respectively. ", "The constructive view of EUR/USD appears unchanged as long as the pair trades above the key 200-day SMA."
  • Eur/usd price analysis: finds support near 100-period SMA on h4, bulls seem reluctant. According to FXStreet on Tuesday, 25 July, "The EUR/USD pair edges higher during the Asian session on Tuesday and for now, seems to have snapped a five-day losing streak, stalling its corrective slide from the highest level since February 2022 touched earlier this week. ", "The US Dollar (USD) ticks down following the recent recovery from a 15-month low witnessed over the past five days and turns out to be a key factor lending some support to the EUR/USD pair. "
  • According to FXStreet on Tuesday, 25 July, "However, relative short-term rates (which have been the main driver of the EUR/USD pair this year), don't support the Euro at all. "

More news about EUR/CHF (EURCHF).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI-Driven Drug Development Meets Biotech Deal-Making and Regulatory Catalysts
AI-designed therapeutics (Insilico's rentosertib showing biological-age reductions) are moving into the clinical mainstream. Large-cap biotech is simultaneously reallocating capital through M&A (Lilly–Merida, $2.9B) and government funding (BARDA–Basilea), while trial failures (ziltivekimab, a 9.4% Novo Nordisk share drop) and upcoming FDA catalysts (the ivonescimab PDUFA on 2026-11-14) drive volatility. The wider AI regulatory and legal climate (Tesla Cybercab probe, xAI's Minnesota loss, OpenAI suits) is tightening, though QAIAx's micro-cap trial claims are speculative and weakly connected.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,327 source documents archived
Query this data → isubstrate.com